Amantadine Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Parkinson's Disease 53.6%
Parkinsonism 9.2%
Influenza 4.6%
Depression 3.9%
Anxiety Disorder 3.3%
Multiple Sclerosis 3.3%
Tremor 3.3%
Fatigue 2.6%
Nasopharyngitis 2.6%
Schizophrenia 2.0%
Supranuclear Palsy 2.0%
Altered State Of Consciousness 1.3%
Amnesia 1.3%
Cerebral Infarction 1.3%
Convulsion 1.3%
Hypertension 1.3%
Listless 1.3%
Angina Pectoris 0.7%
Asthenia 0.7%
B-cell Lymphoma 0.7%
Tremor 9.3%
Serotonin Syndrome 7.4%
Toxic Encephalopathy 7.4%
Corneal Oedema 5.6%
Hallucination 5.6%
Hallucination, Visual 5.6%
Oedema Peripheral 5.6%
Somnolence 5.6%
Urinary Tract Infection 5.6%
Vomiting 5.6%
Confusional State 3.7%
Dystonia 3.7%
Insomnia 3.7%
Pulmonary Oedema 3.7%
Rhabdomyolysis 3.7%
Status Epilepticus 3.7%
Syncope 3.7%
Thrombocytopenia 3.7%
Treatment Noncompliance 3.7%
Vision Blurred 3.7%
Secondary
Parkinson's Disease 45.9%
Drug Use For Unknown Indication 13.1%
Depression 4.4%
Psychotic Disorder 4.3%
Hepatitis C 4.1%
Product Used For Unknown Indication 3.7%
Multiple Sclerosis 2.6%
Tremor 2.5%
Fatigue 2.4%
Influenza 2.4%
Drug Therapy 2.1%
Hypertension 1.7%
Parkinsonism 1.7%
Nutritional Support 1.6%
Dyskinesia 1.5%
Rabies 1.5%
Convulsion 1.3%
Antiviral Treatment 1.2%
Hypothyroidism 1.2%
Suicide Attempt 1.2%
Tremor 13.5%
Corneal Oedema 9.9%
Psychotic Disorder 9.2%
Completed Suicide 8.5%
Death 5.7%
Somnolence 5.7%
Platelet Count Decreased 5.0%
Rhabdomyolysis 4.3%
Vertigo 4.3%
Hallucinations, Mixed 3.5%
Syncope 3.5%
Urinary Tract Infection 3.5%
Vomiting 3.5%
Cerebrovascular Accident 2.8%
Dyskinesia 2.8%
Facial Palsy 2.8%
Hallucination 2.8%
Hypotonia 2.8%
Myoclonus 2.8%
No Adverse Event 2.8%
Concomitant
Parkinson's Disease 25.2%
Multiple Sclerosis 19.3%
Product Used For Unknown Indication 10.6%
Drug Use For Unknown Indication 7.8%
Depression 5.4%
Hypertension 5.0%
Fatigue 4.4%
Pain 3.8%
Relapsing-remitting Multiple Sclerosis 2.7%
Insomnia 2.0%
Anxiety 1.9%
Parkinsonism 1.8%
Prophylaxis 1.7%
Gastrooesophageal Reflux Disease 1.5%
Osteoporosis 1.3%
Headache 1.3%
Schizophrenia 1.3%
Multiple System Atrophy 1.1%
Neuralgia 1.0%
Asthma 1.0%
Tremor 9.0%
Weight Decreased 9.0%
Pathological Gambling 8.8%
Urinary Tract Infection 8.1%
Weight Increased 7.5%
Suicidal Ideation 5.3%
Somnolence 5.1%
Multiple Sclerosis Relapse 5.0%
Parkinson's Disease 4.2%
Pneumonia 4.2%
Vomiting 4.0%
Progressive Multifocal Leukoencephalopathy 3.7%
Wound Infection Staphylococcal 3.7%
White Blood Cell Count Decreased 3.5%
Pain 3.3%
Convulsion 3.1%
Dizziness 3.1%
Pyrexia 3.1%
Syncope 3.1%
Death 2.9%
Interacting
Epilepsy 29.8%
Parkinson's Disease 19.1%
Drug Use For Unknown Indication 17.0%
Depression 4.3%
Dyskinesia 4.3%
Gait Disturbance 4.3%
Initial Insomnia 4.3%
Motor Dysfunction 4.3%
Muscle Rigidity 4.3%
B-cell Lymphoma 2.1%
Routine Health Maintenance 2.1%
Schizophrenia 2.1%
Tardive Dyskinesia 2.1%
Tremor 50.0%
Drug Interaction 12.5%
Malaise 12.5%
Serotonin Syndrome 12.5%
Weight Increased 12.5%